Axonics Modulation Technologies Stock Shares Owned By Insiders
Axonics Modulation Technologies fundamentals help investors to digest information that contributes to Axonics Modulation's financial success or failures. It also enables traders to predict the movement of Axonics Stock. The fundamental analysis module provides a way to measure Axonics Modulation's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axonics Modulation stock.
Axonics |
Axonics Modulation Technologies Company Shares Owned By Insiders Analysis
Axonics Modulation's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Axonics Modulation Shares Owned By Insiders | 1.26 % |
Most of Axonics Modulation's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axonics Modulation Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 1.26% of Axonics Modulation Technologies are shares owned by insiders. This is 91.7% lower than that of the Health Care Equipment & Supplies sector and 91.9% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 87.51% higher than that of the company.
Axonics Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axonics Modulation's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axonics Modulation could also be used in its relative valuation, which is a method of valuing Axonics Modulation by comparing valuation metrics of similar companies.Axonics Modulation is currently under evaluation in shares owned by insiders category among its peers.
Axonics Fundamentals
| Return On Equity | -0.0089 | |||
| Return On Asset | -0.0063 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 3.32 B | |||
| Shares Outstanding | 51.11 M | |||
| Shares Owned By Insiders | 1.26 % | |||
| Shares Owned By Institutions | 87.22 % | |||
| Number Of Shares Shorted | 3.31 M | |||
| Price To Earning | (10.68) X | |||
| Price To Book | 5.46 X | |||
| Price To Sales | 8.40 X | |||
| Revenue | 366.38 M | |||
| Gross Profit | 197.66 M | |||
| EBITDA | 7.78 M | |||
| Net Income | (6.09 M) | |||
| Cash And Equivalents | 213.23 M | |||
| Cash Per Share | 4.53 X | |||
| Total Debt | 27.62 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 10.49 X | |||
| Book Value Per Share | 13.00 X | |||
| Cash Flow From Operations | (2.02 M) | |||
| Short Ratio | 7.14 X | |||
| Earnings Per Share | (0.10) X | |||
| Price To Earnings To Growth | (0.56) X | |||
| Target Price | 72.0 | |||
| Number Of Employees | 797 | |||
| Beta | 0.83 | |||
| Market Capitalization | 3.63 B | |||
| Total Asset | 719.92 M | |||
| Retained Earnings | (380.35 M) | |||
| Working Capital | 445.61 M | |||
| Current Asset | 171.14 M | |||
| Current Liabilities | 12.98 M | |||
| Net Asset | 719.92 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |